Abstract
This is a review article that intends to emphasize the advantages of buccal delivery as an alternative route of administration of anti-inflammatory drugs. The oral cavity has a number of features that make it desirable for drug administration: a rich blood supply that drains directly into the jugular vein, thus bypassing the liver and sparing the drug from first pass metabolism. To understand this point of view, some considerations are done relatively to the oral mucosal structural characteristics with relevance to drug administration, oral mucosal permeability, as well as drug absorption mechanisms through oral cavity. However, to design a buccal delivery system, it is necessary to take in account the residence time of drug formulation in the buccal mucosa. Mucoadhesion mechanism can be a solution to overcome this limitation. For this reason the main buccoadhesive pharmaceutical forms are approached, as well as the importance of oral mucosal in buccal anti-inflammatory drug delivery systems in terms of future perspectives.
Keywords: Anti-inflammatory drugs, buccal mucosa, buccoadhesive drug delivery systems, Transcellular Route, Paracellular Route, Molecular Weight, Penetration Enhancers, MUCOADHESION, Mucoadhesive Polymers, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Mucoadhesive Buccal Systems as a Novel Strategy for Anti-Inflammatory Drugs Administration
Volume: 10 Issue: 3
Author(s): Ana Figueiras, Amelia Vieira, Susana Simoes and Francisco Veiga
Affiliation:
Keywords: Anti-inflammatory drugs, buccal mucosa, buccoadhesive drug delivery systems, Transcellular Route, Paracellular Route, Molecular Weight, Penetration Enhancers, MUCOADHESION, Mucoadhesive Polymers, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Abstract: This is a review article that intends to emphasize the advantages of buccal delivery as an alternative route of administration of anti-inflammatory drugs. The oral cavity has a number of features that make it desirable for drug administration: a rich blood supply that drains directly into the jugular vein, thus bypassing the liver and sparing the drug from first pass metabolism. To understand this point of view, some considerations are done relatively to the oral mucosal structural characteristics with relevance to drug administration, oral mucosal permeability, as well as drug absorption mechanisms through oral cavity. However, to design a buccal delivery system, it is necessary to take in account the residence time of drug formulation in the buccal mucosa. Mucoadhesion mechanism can be a solution to overcome this limitation. For this reason the main buccoadhesive pharmaceutical forms are approached, as well as the importance of oral mucosal in buccal anti-inflammatory drug delivery systems in terms of future perspectives.
Export Options
About this article
Cite this article as:
Figueiras Ana, Vieira Amelia, Simoes Susana and Veiga Francisco, Mucoadhesive Buccal Systems as a Novel Strategy for Anti-Inflammatory Drugs Administration, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2011; 10 (3) . https://dx.doi.org/10.2174/1871523011109030190
DOI https://dx.doi.org/10.2174/1871523011109030190 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
“Bridge Proteins” Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics
Current Protein & Peptide Science Therapeutically-induced Autoantibodies in Patients Treated with Recombinant Hematopoietic Growth Factors: A Brief Summary
Current Pharmaceutical Design Molecular Approach to Targeted Therapy for Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Applications of Lipid based Formulation Technologies in the Delivery of Biotechnology-based Therapeutics
Current Pharmaceutical Biotechnology Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus
Current Pharmaceutical Design Editorial [Autoinflammatory Disorders of Childhood: Continued Major Breakthroughs]
Current Rheumatology Reviews Biotechnological Manufacturing Options for Organic Chemistry
Mini-Reviews in Organic Chemistry Advances in the Knowledge and Clinical Applications of Lactic Acid Bacteria as Probiotics in the Urogenital Tract
Current Women`s Health Reviews Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical Trial
Reviews on Recent Clinical Trials Neoplastic Conditions in the Context of HIV-1 Infection
Current HIV Research Extracellular Proteases as Targets for Drug Development
Current Protein & Peptide Science Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Recent Advances on the Machine Learning Methods in Identifying Phage Virion Proteins
Current Bioinformatics Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
Current Pharmaceutical Design Electrochemical Determination of Non-Steroidal Anti-Inflammatory Drugs
Current Analytical Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Mucosal Immune Regulation and Vaccines for Helicobacter-associated Gastritis
Current Chemical Biology Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Modulation of Tumour-Related Signaling Pathways by Natural Pentacyclic Triterpenoids and their Semisynthetic Derivatives
Current Medicinal Chemistry Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma
Current Neuropharmacology